dacarbazine and its Impurities
Dacarbazine was approved for medical use in the United States in 1975. It is also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma.. Reference standards of Dacarbazine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

 
	
			                                   
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				![4H-Imidazo[4,5-d][1,2,3]triazin-4-one PA 04 0021000](https://www.pharmaffiliates.com/pimages/PA040021000.jpg) 
																				 
																				 
																				 
 
 
 
